AzTrials
AzTrials

Heart Failure, CongestiveNCT00378950

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

A study testing Teach to Goal (TTG) and Brief Educational Intervention (BEI) in people with Heart Failure, Congestive, run by University of North Carolina, Chapel Hill at 4 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Heart failure (HF) affects 5 million people in the United States. Health literacy, which is the ability to read and comprehend important medical information, plays an important role in the health of individuals with HF. Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Heart Failure, Congestive
What is being tested?
Teach to Goal (TTG) and Brief Educational Intervention (BEI)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
605 participants
Where
4 sitesUnited States
Study dates
Mar 2007to Feb 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinical diagnosis of HF
  • Currently prescribed a Loop diuretic medication
  • At least one of the following findings:
  • Chest x-ray consistent with HF (current or past x-ray with probable or definite pulmonary edema)
  • Reduced ejection fraction on echocardiogram (ECHO), multiple gate acquisition scan (MUGA), or cardiac catheterization (less than 50%)
  • Left ventricular hypertrophy (LVH) or diastolic filling pattern on ECHO
Show all 10Show fewer
  • Elevated B-type natriuretic peptide
  • Currently experiencing New York Heart Association Class II-IV symptoms or has experienced these symptoms in the 6 months prior to study entry
  • Has a working telephone
  • Speaks English or Spanish

Who cannot join

  • Patients will be ineligible if they meet ONE the following criteria:
  • Sight - Inability to see printed educational material well enough to utilize it
  • Cognition - Moderate to severe dementia (If medical notes state "Severe Dementia" or as determined by administering the study's cognitive screener)
  • Surgery -Valuvular disease rated as severe (mitral stenosis, aortic stenosis or aortic regurgitation) or valuvular surgery planned within a year (i.e., bypass, angioplasty, valve replacement, heart transplant)
  • Terminal Illness - Possessing a terminal illness with prognosis of 1 year or less
  • Dialysis - Currently on dialysis or anticipated to start dialysis within 1 year
Show all 9Show fewer
  • Oxygen Dependant - Using concentrate oxygen intermittent or continuously for COPD
  • Management of Care - Not able to control medications
  • Other Studies -Patient enrolled (past or present) in another study where intervention status would interfere with pure outcome of this or other study

Trial locations and contacts

4 sites in 1 country.

United States4 sites
  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599

  • Northwestern Medical Faculty Foundation Clinics & Northwestern Memorial Hospital Chicago

    Chicago, Illinois, 60611

  • University of California - Los Angeles (UCLA)

    Los Angeles, California, 90024

  • University of California at San Francisco, San Francisco General Hospital

    San Francisco, California, 94143

Other trials in United States

About this study

Official title: Health Literacy and Self-Management in Heart Failure

Heart failure (HF) affects 5 million people in the United States. Health literacy, which is the ability to read and comprehend important medical information, plays an important role in the health of individuals with HF. This study will evaluate the effectiveness of an educational program developed for various levels of health literacy at improving medical outcomes and quality of life in individuals with HF.

Read the detailed description

HF is a complicated disease that often requires individuals to carefully monitor their condition. Individuals with HF must follow strict medication regimens, adhere to diet and exercise recommendations, and closely monitor symptoms and changes in weight. Individuals with low health literacy skills may have a harder time comprehending medication dosing instructions, educational materials, and the overall complexity of managing HF than individuals with higher health literacy skills. Programs that focus on building self-care skills have been proven to reduce the rate of hospitalizations among individuals with HF; only one study, however, has specifically examined the importance of health literacy in the effectiveness of these programs. Teach to Goal (TTG), a program that focuses on developing self-care skills while incorporating medical information for various health literacy levels, may improve medical outcomes in individuals with HF. The purpose of this study is to evaluate the effectiveness of TTG at improving hospitalization and death rates, quality of life, and self-care behaviors among individuals with HF.

This 1-year study will enroll individuals with HF. Eligible participants will attend a baseline study visit and complete survey questionnaires. Participants will then be randomly assigned to either TTG or a control group. The TTG group will partake in a 30- to 60-minute educational session, which will focus on improving self-care skills. They will also receive literacy-sensitive printed materials about monitoring body weight and swelling in the legs, medication administration, and a sodium reduction and exercise plan. Control group participants will partake in a shorter educational session and will receive fewer printed materials. All participants will be provided with a digital scale to self-monitor their weight at home. The TTG group will receive follow-up phone calls on Days 3, 7, 14, 21, and 28, during which study staff will assess participants' progress and will provide additional support and training as necessary. Both groups will receive phone calls at Months 1, 6, and 12. During these calls, number of hospitalizations, quality of life, and changes in self-care behavior and knowledge will be evaluated, but participants will not receive any additional training.

Being tested
Teach to Goal (TTG), Brief Educational Intervention (BEI)
Keywords
Congestive Heart Failure
Medical subject headings
Heart Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Teach to Goal (TTG)Behavioural

    Also called TTG

    The TTG program includes the Brief Educational Intervention (BEI) educational intervention, as well as education about diuretic self adjustment. In addition, follow-up phone calls are given to the TTG group to further reinforce the initial training and provide further training so participants will master the task.

  • Brief Educational Intervention (BEI)Behavioural

    Also called BEI

    The BEI is a one hour educational session on CHF, symptom recognition, diet, exercise, and daily checkups.

Study groups in NCT00378950
Study groupRoleWhat they receive
1Active comparatorParticipants will receive a 1-hour education session about CHF, symptom recognition, diet, exercise, and daily check ups.
Receives: Behavioral: Brief Educational Intervention (BEI)
2ExperimentalParticipants will receive a 1-hour education session about CHF, symptom recognition, diet, exercise, and daily check ups, as well as additional information on diuretic self adjustment. This group will then get several follow-up phone calls over the course of the year to reinforce these topics and help them master the knowledge and encourage behavior and lifestyle changes to align with these topics.
Receives: Behavioral: Teach to Goal (TTG)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. All cause hospitalization

    Measured: Measured at 12 months

  2. All cause mortality

    Measured: Measured at 12 months

Secondary outcomes (3)
  1. Heart failure quality-of-life

    Measured: Measured at 1, 6, 12 months

  2. Heart failure-related hospitalizations

    Measured: Measured at 12 months

  3. Difference between groups for adoption of appropriate self-management knowledge and behaviors

    Measured: Measured at 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2006 (estimated)
  2. Study startMar 2007
  3. Primary completionFeb 2011
  4. Study completionFeb 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
605 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00378950
Sponsor's protocol ID
439
Other IDs
R01HL081257-01A1
Status last verified
May 2016
First submitted
20 Sep 2006
Last updated
4 May 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • DeWalt DA, Broucksou KA, Hawk V, Baker DW, Schillinger D, Ruo B, Bibbins-Domingo K, Holmes M, Weinberger M, Macabasco-O'Connell A, Pignone M. Comparison of a one-time educational intervention to a teach-to-goal educational intervention for self-management of heart failure: design of a randomized controlled trial. BMC Health Serv Res. 2009 Jun 11;9:99. doi: 10.1186/1472-6963-9-99.

    PubMed 19519904
  • Baker DW, DeWalt DA, Schillinger D, Hawk V, Ruo B, Bibbins-Domingo K, Weinberger M, Macabasco-O'Connell A, Pignone M. "Teach to goal": theory and design principles of an intervention to improve heart failure self-management skills of patients with low health literacy. J Health Commun. 2011;16 Suppl 3(Suppl 3):73-88. doi: 10.1080/10810730.2011.604379.

    PubMed 21951244
  • Baker DW, Dewalt DA, Schillinger D, Hawk V, Ruo B, Bibbins-Domingo K, Weinberger M, Macabasco-O'Connell A, Grady KL, Holmes GM, Erman B, Broucksou KA, Pignone M. The effect of progressive, reinforcing telephone education and counseling versus brief educational intervention on knowledge, self-care behaviors and heart failure symptoms. J Card Fail. 2011 Oct;17(10):789-96. doi: 10.1016/j.cardfail.2011.06.374. Epub 2011 Jul 23.

    PubMed 21962415
  • Macabasco-O'Connell A, DeWalt DA, Broucksou KA, Hawk V, Baker DW, Schillinger D, Ruo B, Bibbins-Domingo K, Holmes GM, Erman B, Weinberger M, Pignone M. Relationship between literacy, knowledge, self-care behaviors, and heart failure-related quality of life among patients with heart failure. J Gen Intern Med. 2011 Sep;26(9):979-86. doi: 10.1007/s11606-011-1668-y. Epub 2011 Mar 3.

    PubMed 21369770
  • DeWalt DA, Schillinger D, Ruo B, Bibbins-Domingo K, Baker DW, Holmes GM, Weinberger M, Macabasco-O'Connell A, Broucksou K, Hawk V, Grady KL, Erman B, Sueta CA, Chang PP, Cene CW, Wu JR, Jones CD, Pignone M. Multisite randomized trial of a single-session versus multisession literacy-sensitive self-care intervention for patients with heart failure. Circulation. 2012 Jun 12;125(23):2854-62. doi: 10.1161/CIRCULATIONAHA.111.081745. Epub 2012 May 9.

    PubMed 22572916

Questions about this trial

What is this clinical trial studying?

A study testing Teach to Goal (TTG) and Brief Educational Intervention (BEI) in people with Heart Failure, Congestive, run by University of North Carolina, Chapel Hill at 4 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

All cause hospitalization (time frame: Measured at 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00378950, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in